These data highlighted a positive feedback loop between GLI1 and PHGDH, suggesting that pharmacological inhibition of GLI factors, through the administration of JC19 or GANT61 [20, 46], could improve the sensitivity of CRC cell lines to 5-FU administration. This evidence concerns the gene GLI1 and colorectal carcinoma.